Neurotransmitter and Related Metabolic Profiling in the Nucleus Accumbens of Chronic Unpredictable Mild Stress-Induced Anhedonia-Like Rats
Open Access
- 29 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 16, 862683
Abstract
Major depressive disorder (MDD) is a serious mental disorder that affects many people. The neurotransmitter deficiency hypothesis has been the crux of much research on the treatment of depression. Anhedonia, as a core symptom, was closely associated with altered levels of 5-hydroxytryptamine (5-HT), dopamine (DA), and diverse types of glutamate (Glu) receptors in the nucleus accumbens (NAc). However, there were no reports showing how Glu changed in the NAc, and there were other unreported molecules involved in modulating stress-induced anhedonia. Thus, we investigated changes in neurotransmitters and their related metabolites in GABAergic, serotonergic and catecholaminergic pathways in the NAc of a rat model of chronic unpredictable mild stress- (CUMS-) induced anhedonia-like behavior. Then, liquid chromatography-tandem mass spectrometry (LC-MS/MS) was employed to detect target neurotransmitters and related metabolites in the NAc. Finally, the Western blot was used to assess the expression of key enzymes and receptors. Here, we found that the 5-HT level in anhedonia-susceptible (Sus) rats was increased while the Glu level decreased. DA did not show a significant change among CUMS rats. Correspondingly, we detected a reduction in monoamine oxidase-A (MAOA) and Glu receptor 1 levels in anhedonia-Sus rats while Glu receptor 2 (GluR2) and NMDA2B levels were increased in anhedonia-resilient (Res) rats. We also found that the levels of glutamine (Gln), kynurenic acid (Kya), histamine (HA), L-phenylalanine (L-Phe), and tyramine (Tyra) were changed after CUMS. These alterations in neurotransmitters may serve as a new insight into understanding the development of anhedonia-like behavior in depression.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFA0505700)
- National Natural Science Foundation of China (NO.81820108015)
- Chinese Academy of Medical Sciences (2019PT320002)
This publication has 38 references indexed in Scilit:
- Cell-Type Specific Expression of p11 Controls Cocaine RewardBiological Psychiatry, 2014
- Trait anhedonia is associated with reduced reactivity and connectivity of mesolimbic and paralimbic reward pathwaysJournal of Psychiatric Research, 2013
- Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of miceBehavioural Brain Research, 2013
- The brain reward circuitry in mood disordersNature Reviews Neuroscience, 2013
- The Stability of NR2B in the Nucleus Accumbens Controls Behavioral and Synaptic Adaptations to Chronic StressBiological Psychiatry, 2013
- Novel δ1-receptor agonist KNT-127 increases the release of dopamine and l-glutamate in the striatum, nucleus accumbens and median pre-frontal cortexNeuropharmacology, 2012
- Neurochemical consequence of steroid abuse: Stanozolol-induced monoaminergic changesSteroids, 2012
- Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable StressNeuropsychopharmacology, 2010
- Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in ratsBehavioural Brain Research, 2008
- Brain Reward Regulated by AMPA Receptor Subunits in Nucleus Accumbens ShellJournal of Neuroscience, 2006